SNX Form 4: Dennis Polk sells shares under 10b5-1 plan

Rhea-AI Filing Summary

TD SYNNEX (SNX) director Dennis Polk reported insider sales executed for the Polk family trust under a Rule 10b5-1 trading plan. The reporting person, who is a director and identified as a Hyve Solutions executive, sold shares on 09/04/2025 pursuant to the plan adopted October 13, 2024. The Form 4 shows dispositions of 100 shares at an average price near $147.82, 2,600 shares at an average price near $148.45, and 300 shares at an average price near $149.14. The reporting attorney-in-fact signed the form on 09/05/2025. The filing discloses the sales were made by the Polk family trust of which the reporting person is a trustee and offers to provide transaction-level price details on request.

Positive

• Sales executed under a Rule 10b5-1 trading plan, which provides pre-clearance and reduces concerns about opportunistic timing
• Clear disclosure of weighted-average price ranges and an offer to provide transaction-level price details upon request, enhancing transparency
• Reporting person identified with roles (director and Hyve Solutions executive) so investors can assess potential conflicts

Negative

• Insider dispositions reduced holdings (reported disposals of 100, 2,600 and 300 shares), which may be viewed negatively by some investors

Insights

Corporate Governance Expert

TL;DR: Routine, pre-planned insider sales under a 10b5-1 plan; disclosure aligns with governance best practices.

The filing documents planned disposals under a Rule 10b5-1 trading plan adopted October 13, 2024, which reduces the likelihood these transactions were opportunistic or based on inside information. The reporting person remains identified as a director and trustee, and the Form 4 provides weighted-average price ranges and an offer to supply per-transaction prices on request, supporting transparency. This is a standard governance disclosure rather than a material corporate event.

Securities Analyst

TL;DR: Modest insider dispositions disclosed; not clearly material to company valuation or control.

The reported dispositions (100, 2,600 and 300 shares) occurred at prices roughly $147.82–$149.14 per share and were executed from a family trust. Absent additional information on total insider holdings or size relative to outstanding shares, these sales alone do not indicate a material change in ownership or signal about company performance. The 10b5-1 plan context reduces interpretive weight.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POLK DENNIS

(Last) (First) (Middle)

44201 NOBEL DRIVE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Hyve Solutions Executive

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2025		S(1)		100	D	$147.82(2)	87,560	I	By Trust
Common Stock	09/04/2025		S(1)		2,600	D	$148.45(3)	84,960	I	By Trust
Common Stock	09/04/2025		S(1)		300	D	$149.14(4)	84,660	I	By Trust
Common Stock								35,295	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2024, on behalf of the Polk family trust of which the reporting person is a trustee.

2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $147.815 to $147.82. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

3. Represents the weighted average sales price for a number of transactions effected at prices ranging from $148.05 to $148.99. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

4. Represents the weighted average sales price for a number of transactions effected at prices ranging from $149.10 to $149.22. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

	/s/ Cheryl Grant, attorney-in-fact	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Dennis Polk report on Form 4 for SNX?

The Form 4 reports that Dennis Polk sold shares of TD SYNNEX (SNX) on 09/04/2025 from the Polk family trust pursuant to a Rule 10b5-1 trading plan.

How many shares did the reporting person dispose of in the filing?

The filing shows reported dispositions of 100, 2,600, and 300 shares on 09/04/2025.

At what prices were the SNX shares sold?

The sales were effected at weighted-average prices reported near $147.82, $148.45, and $149.14, with price ranges disclosed in the filing.

Was the sale part of a pre-arranged plan?

Yes. The sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2024.

Who signed the Form 4 and when?

The Form 4 was signed by /s/ Cheryl Grant, attorney-in-fact on 09/05/2025.